Donor-Derived Viral Specific T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-Derived Viral Specific T-cells, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant [Phase 2]